Bernie Sanders Takes on US Drug Prices with Potential Subpoenas for J&J and Merck
XTalks
JANUARY 24, 2024
This disparity can be attributed to various factors, including the lack of government regulation on drug prices and the complex web of negotiations between drug manufacturers, insurers and pharmacy benefit managers. ” If authorized, Sanders said these would be the first subpoenas issued by the HELP Committee since 1981.
Let's personalize your content